These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8930784)
1. Lack of pharmacokinetic interaction between buspirone and haloperidol in patients with schizophrenia. Huang HF; Jann MW; Wei FC; Chang TP; Chen JS; Juang DJ; Lin SK; Lam YW; Chien CP; Chang WH J Clin Pharmacol; 1996 Oct; 36(10):963-9. PubMed ID: 8930784 [TBL] [Abstract][Full Text] [Related]
2. An open trial of buspirone added to neuroleptics in schizophrenic patients. Goff DC; Midha KK; Brotman AW; McCormick S; Waites M; Amico ET J Clin Psychopharmacol; 1991 Jun; 11(3):193-7. PubMed ID: 2066458 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range. Dockens RC; Salazar DE; Fulmor IE; Wehling M; Arnold ME; Croop R J Clin Pharmacol; 2006 Nov; 46(11):1308-12. PubMed ID: 17050795 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of buspirone extended-release tablets: a single-dose study. Sakr A; Andheria M J Clin Pharmacol; 2001 Jul; 41(7):783-9. PubMed ID: 11452712 [TBL] [Abstract][Full Text] [Related]
6. A study of pharmacokinetic interaction between buspirone and alprazolam at steady state. Buch AB; Van Harken DR; Seidehamel RJ; Barbhaiya RH J Clin Pharmacol; 1993 Nov; 33(11):1104-9. PubMed ID: 8300893 [TBL] [Abstract][Full Text] [Related]
7. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol. Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415 [TBL] [Abstract][Full Text] [Related]
8. Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol. Suzuki A; Yasui-Furukori N; Mihara K; Kondo T; Furukori H; Inoue Y; Kaneko S; Otani K Ther Drug Monit; 2003 Apr; 25(2):192-6. PubMed ID: 12657913 [TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses]. Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M Encephale; 1995; 21(6):417-24. PubMed ID: 8674466 [TBL] [Abstract][Full Text] [Related]
10. Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidol. Yasui N; Otani K; Kondo T; Suzuki A; Furukori H; Kaneko S; Inoue Y Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):485-92. PubMed ID: 9612845 [TBL] [Abstract][Full Text] [Related]
11. Effect of rifampin on the plasma concentration and the clinical effect of haloperidol concomitantly administered to schizophrenic patients. Kim YH; Cha IJ; Shim JC; Shin JG; Yoon YR; Kim YK; Kim JI; Park GH; Jang IJ; Woo JI; Shin SG J Clin Psychopharmacol; 1996 Jun; 16(3):247-52. PubMed ID: 8784658 [TBL] [Abstract][Full Text] [Related]
12. No interaction between desipramine and bromperidol. Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y Prog Neuropsychopharmacol Biol Psychiatry; 1996 Oct; 20(7):1265-71. PubMed ID: 8938825 [TBL] [Abstract][Full Text] [Related]